Modern management of myelofibrosisCERVANTES, Francisco.British journal of haematology. 2005, Vol 128, Num 5, pp 583-592, issn 0007-1048, 10 p.Article

Practical Management of Patients With Chronic Myeloid LeukemiaCERVANTES, Francisco; MAURO, Michael.Cancer. 2011, Vol 117, Num 19, pp 4343-4354, issn 0008-543X, 12 p.Article

Myelofibrosis: an update on current pharmacotherapy and future directionsCERVANTES, Francisco; MARTINEZ-TRILLOS, Alejandra.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 7, pp 873-884, issn 1465-6566, 12 p.Article

Transferts de matières sous l'effet de la chaleur en cours de fragmentation, restructuration et cuisson des produits carnés divisés = Mass transfers by heat during fragmentation, restructuration and cooking of comminuted meat productsCALDERON CERVANTES, Francisco.1984, 134 f.-[52] p. de plThesis

Transferts de matières sous l'effet de la chaleur en cours de fragmentation, restructuration et cuisson des produits carnés divisésCALDERON CERVANTES, Francisco.1984, 197 pThesis

Azo dye decolorization assisted by chemical and biogenic sulfidePRATO-GARCIA, Dorian; CERVANTES, Francisco J; BUITRON, Germán et al.Journal of hazardous materials (Print). 2013, Vol 250-251, pp 462-468, issn 0304-3894, 7 p.Article

Impact and application of electron shuttles on the redox (bio)transformation of contaminants : A reviewVAN DER ZEE, Frank P; CERVANTES, Francisco J.Biotechnology advances. 2009, Vol 27, Num 3, pp 256-277, issn 0734-9750, 22 p.Article

Blood cell activation in myeloproliferative neoplasmsCERVANTES, Francisco; ARELLANO-RODRIGO, Eduardo; ALVAREZ-LARRAN, Alberto et al.Haematologica (Roma). 2009, Vol 94, Num 11, pp 1484-1488, issn 0390-6078, 5 p.Article

Survival in young patients with intermediate-/high-risk myelofibrosis : Estimates derived from databases for non transplant patientsSIRAGUSA, Sergio; PASSAMONTI, Francesco; CERVANTES, Francisco et al.American journal of hematology. 2009, Vol 84, Num 3, pp 140-143, issn 0361-8609, 4 p.Article

Myelofibrosis with myeloid metaplasia : Diagnosis, prognostic factors, and stagingCERVANTES, Francisco; BAROSI, Giovanni.Seminars in oncology. 2005, Vol 32, Num 4, pp 395-402, issn 0093-7754, 8 p.Article

Simultaneous occurrence of multiple myeloma and chronic myeloid leukemiaALVAREZ-LARRAN, Alberta; ROZMAN, Maria; CERVANTES, Francisco et al.Haematologica (Roma). 2001, Vol 86, Num 8, issn 0390-6078, p. 894Article

Nitrogen removal from wastewaters at low C/N ratios with ammonium and acetate as electron donorsCERVANTES, Francisco J; DE LA ROSA, David A; GOMEZ, Jorge et al.Bioresource technology. 2001, Vol 79, Num 2, pp 165-170, issn 0960-8524Article

Characterization of the hydrodynamics inside a practical cell with a rotating disk electrodeGONZALEZ, Jesus; REAL, Cesar; HOYOS, Luis et al.Journal of electroanalytical chemistry (1992). 2011, Vol 651, Num 2, pp 150-159, issn 1572-6657, 10 p.Article

Aqueous solution reaction to synthesize ammonium hexachloroplatinate and its crystallographic and thermogravimetric characterizationVERDE-GOMEZ, Ysmael; ALONSO-NUNEZ, Gabriel; CERVANTES, Francisco et al.Materials letters (General ed.). 2003, Vol 57, Num 30, pp 4667-4672, issn 0167-577X, 6 p.Article

Simultaneous biodegradation of phenol and carbon tetrachloride mediated by humic acidsMARTINEZ, Claudia M; ALVAREZ, Luis H; CERVANTES, Francisco J et al.Biodegradation (Dordrecht). 2012, Vol 23, Num 5, pp 635-644, issn 0923-9820, 10 p.Article

The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosisSUSINI, Maria C; GUGLIELMELLI, Paola; CAZZOLA, Mario et al.British journal of haematology. 2013, Vol 162, Num 3, pp 424-427, issn 0007-1048, 4 p.Article

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia veraALVAREZ-LARRAN, Alberto; PEREIRA, Arturo; TERUEL, Anabel et al.Blood. 2012, Vol 119, Num 6, pp 1363-1369, issn 0006-4971, 7 p.Article

XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemiaGUILLEM, Vicent M; CERVANTES, Francisco; MARTINEZ, Jesús et al.American journal of hematology. 2010, Vol 85, Num 7, pp 482-486, issn 0361-8609, 5 p.Article

Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemiaSAN JOSE-ENERIZ, Edurne; AGIRRE, Xabier; HEINIGER, Anabel et al.European journal of cancer (1990). 2009, Vol 45, Num 10, pp 1877-1889, issn 0959-8049, 13 p.Article

Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemiaROMAN-GOMEZ, Jose; JIMENEZ-VELASCO, Antonio; PROSPER, Felipe et al.Oncogene (Basingstoke). 2005, Vol 24, Num 48, pp 7213-7223, issn 0950-9232, 11 p.Article

Late response to donor lymphocyte infusions in patients with chronic myelold leukemia relapsing after allogeneic stem cell transplantationGOMEZ, Marta; URBANO-ISPIZUA, Alvaro; CERVANTES, Francisco et al.Haematologica (Roma). 2002, Vol 87, Num 9, pp 1003-1005, issn 0390-6078Article

Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger : presenting features, evolution and survivalCERVANTES, Francisco; BAROSI, Giovanni; HERNANDEZ-BOLUDA, Juan-Carlos et al.European journal of haematology. 2001, Vol 66, Num 5, pp 324-327, issn 0902-4441Article

Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia : Relationship with thrombosis occurrence and JAK2 V617F allele burdenARELLANO-RODRIGO, Eduardo; ALVAREZ-LARRAN, Alberto; REVERTER, Juan-Carlos et al.American journal of hematology. 2009, Vol 84, Num 2, pp 102-108, issn 0361-8609, 7 p.Article

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemiaLEE, Stephanie J; KUKREJA, Manisha; HALTER, Joerg et al.Blood. 2008, Vol 112, Num 8, pp 3500-3507, issn 0006-4971, 8 p.Article

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)TEFFERI, Ayalew; BAROSI, Giovanni; CORTES, Jorge et al.Blood. 2006, Vol 108, Num 5, pp 1497-1503, issn 0006-4971, 7 p.Article